Funding

#U01DA048525 Title: First-In-Human Study of a Humanized Anti-Cocaine Monoclonal Antibody
Start: 07-01-2019 / End: 04-30-2022 Primary Investigators: Andrew B Norman Investigators: Dasenbrock-Gamm, Hanna; Kirley, Terence; Nelson, Erik; Norman, Andrew; Ridgway, William; Webster, Rose; Welge, Jeffrey Grant Sponsor: National Institute on Drug Abuse Grant Amount: $4,770,702.00 (level: Federal)

#U01DA050330 Title: IND-Enabling Pre-Clinical Studies to Accelerate the Clinical Development of a Humanized Anti-Cocaine Monoclonal Antibody
Start: 09-15-2019 / End: 07-31-2022 Primary Investigators: Andrew B Norman Investigators: Amlal, Hassane; Crutchfield, Christopher; Dasenbrock-Gamm, Hanna; Kirley, Terence; Norman, Andrew; Rubinstein, Jack; Webster, Rose Grant Sponsor: National Institute on Drug Abuse Grant Amount: $1,796,316.00 (level: Federal)

#U01DA050330 Title: IND-Enabling Pre-Clinical Studies to Accelerate the Clinical Development of a Humanized Anti-Cocaine Monoclonal Antibody
Start: 09-15-2019 / End: 07-31-2024 Primary Investigators: Andrew B Norman Investigators: Amlal, Hassane; Crutchfield, Christopher; Kirley, Terence; Norman, Andrew; Rubinstein, Jack; Webster, Rose; Wetzel, Hanna Grant Sponsor: National Institute on Drug Abuse (level: Federal)

#U01DA048525 Title: First-In-Human Study of a Humanized Anti-Cocaine Monoclonal Antibody
Start: 07-01-2019 / End: 04-30-2023 Primary Investigators: Andrew B Norman Investigators: Geracioti, Thomas MD; Kirley, Terence PhD; Nelson, Erik MD; Ridgway, William MD; Webster, Rose ; Welge, Jeffrey PhD Grant Sponsor: National Institute on Drug Abuse Grant Amount: $8474481.00